Moderna
MRNA
#1830
Rank
A$16.29 B
Marketcap
A$41.70
Share price
8.67%
Change (1 day)
-37.36%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -A$4.97 Billion

According to Moderna 's latest financial reports the company's current earnings are A$2.20 Billion. In 2024 the company made an earning of -A$5.4 Billion, an increase over its 2023 earnings that were of -A$5.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$4.97 Billion-8.02%
2024 -A$5.4 Billion-8.22%
2023 -A$5.88 Billion-140.65%
2022 A$14.45 B-27.81%
2021 A$20.02 B-1911.15%
2020 -A$1.11 Billion44.7%
2019 -A$0.77 Billion28.63%
2018 -A$0.6 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-A$71.41 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.76 B-834.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$62.88 Million-98.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.19 B-104.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.71 B-622.07%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
-A$0.12 Billion-97.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B-1,130.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA